Global Pharmaceutical Market Size To Worth USD 3,528.9 Billion by 2035 | CAGR of 6.49%
Category: HealthcareGlobal Pharmaceutical Market Size To Worth USD 3,528.9 Billion by 2035 | CAGR of 6.49%
According to a research report published by Spherical Insights & Consulting, The Global Pharmaceutical Market Size was estimated at USD 1,653.7 Billion in 2024 and Expected to Grow from USD 1,746.4 Billion in 2025 to USD 3,528.9 Billion by 2035, at a CAGR of 6.49% during the forecast period 2025-2035.
Get more details on this report -
Browse key industry insights spread across 230 pages with 110 Market data tables and figures & charts from the report on the "Global Pharmaceutical Market Size, Share, and COVID-19 Impact Analysis, By Molecule Type (Conventional Drugs (Small Molecules), Biologics & Biosimilars (Large Molecules), and Others), By Product (Branded and Generics), By Type (Prescription and OTC), By Disease (Cancer, Cardiovascular Diseases, Diabetes, Infectious Diseases, Neurological Disorders, Respiratory Diseases, Autoimmune Diseases, Mental Health Disorders, Gastrointestinal Disorders, Women’s Health Issues, Genetic and Rare Genetic Diseases, Dermatological Conditions, Obesity, Renal Diseases, Liver Conditions, Hematological Disorders, Eye Conditions, Infertility, Allergies, and Others), By Route Of Administration (Oral, Parenteral, Topical, Inhalations, and Others), By Formulation (Tablets, Sprays, Injectable, Capsules, and Others), By Age Group (Adults, Children & Adolescents, and Geriatric), By End-User (Hospitals, Clinics, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035." Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/pharmaceutical-market
The pharmaceutical market is the industry that creates, manufactures, and distributes medications and treatments. These companies, organizations, and entities make, market, and sell pharmaceutical products, including prescription drugs, over-the-counter (OTC) medications, vaccinations, and other therapeutic items. The pharmaceutical business, one of the most strictly regulated sectors, has a long history of manufacturing high-quality pharmaceutical products for human use that have the desired pharmacotherapeutic effects for the treatment of a variety of diseases. The primary factors driving the market's growth are the introduction of advanced products and the increased prevalence of illnesses including diabetes, cancer, and infectious diseases. The aging of the population, the rise in the prevalence of chronic diseases, the global expansion of government spending on healthcare, and the tremendous efforts to lower the cost of pharmaceuticals are all factors driving the pharmaceutical industry's growth. The frequency of chronic diseases, the aging population, increased government spending on healthcare, and significant efforts to reduce drug prices are all factors driving the pharmaceutical industry's expansion. However, a serious lack of trained workers for creating medications that demand specialized skill sets restricted market growth. Medical equipment and some research companies are the only businesses with these skill sets.
The conventional drugs segment hold the highest share in 2024 and is anticipated to grow at a significant CAGR during the projected timeframe.
Based on the molecule type, the pharmaceutical market is classified into conventional drugs (small molecules), biologics & biosimilars (large molecules), and others. Among these, the conventional drugs segment hold the highest share in 2024 and is anticipated to grow at a significant CAGR during the projected timeframe. Conventional drugs are widely used due to their oral bioavailability, consistent pharmacokinetics, and well-established production methods.
The branded segment hold the highest share in 2024 and is anticipated to grow at a significant CAGR during the projected timeframe.
Based on the product, the pharmaceutical market is divided into branded and generics. Among these, the branded segment hold the highest share in 2024 and is anticipated to grow at a significant CAGR during the projected timeframe. The branded category is a result of the growing demand for the creation of novel therapies to address a variety of ailments, the expanding R&D and approval of novel pharmaceuticals, and the rising prevalence of chronic diseases.
The prescription segment hold the highest share in 2024 and is anticipated to grow at a significant CAGR during the projected timeframe.
Based on the type, the pharmaceutical market is classified into prescription and OTC. Among these, the prescription segment hold the highest share in 2024 and is anticipated to grow at a significant CAGR during the projected timeframe. The market's leading players have been investing more in research and development (R&D) to create new medications, which are primarily used to treat chronic illnesses, which has led to the prescription segment.
The cancer segment hold the highest share in 2024 and is anticipated to grow at a significant CAGR during the projected timeframe.
Based on the disease, the pharmaceutical market is classified into cancer, cardiovascular diseases, diabetes, infectious diseases, neurological disorders, respiratory diseases, autoimmune diseases, mental health disorders, gastrointestinal disorders, women’s health issues, genetic and rare genetic diseases, dermatological conditions, obesity, renal diseases, liver conditions, hematological disorders, eye conditions, infertility, allergies, and others. Among these, the cancer segment hold the highest share in 2024 and is anticipated to grow at a significant CAGR during the projected timeframe. Numerous types of cancer are becoming increasingly prevalent worldwide, which has raised the demand for novel and efficient therapies and stimulated a lot of investment and research in this area.
The oral segment hold the highest share in 2024 and is anticipated to grow at a significant CAGR during the projected timeframe.
Based on the route of administration, the pharmaceutical market is classified into oral, parenteral, topical, inhalations, and others. Among these, the oral segment hold the highest share in 2024 and is anticipated to grow at a significant CAGR during the projected timeframe. The oral route is increasingly common due to it is well-known and has a proven safety record, which is preferred by both patients and medical professionals.
The tablets segment hold the highest share in 2024 and is anticipated to grow at a significant CAGR during the projected timeframe.
Based on the formulation, the pharmaceutical market is classified into tablets, sprays, injectable, capsules, and others. Among these, the tablets segment hold the highest share in 2024 and is anticipated to grow at a significant CAGR during the projected timeframe. The easiest to manufacture for a variety of specialties, such as anti-diabetics, anti-inflammatory, antacids, vitamins, and antiallergics, are tablets.
The adults segment hold the highest share in 2024 and is anticipated to grow at a significant CAGR during the projected timeframe.
Based on the age group, the pharmaceutical market is classified into adults, children & adolescents, and geriatric. Among these, the adults segment hold the highest share in 2024 and is anticipated to grow at a significant CAGR during the projected timeframe. Adults between the ages of 15 and 64 make up the largest group of individuals use prescription medications. In the adult population, ACE inhibitors, analgesics, antidepressants, and lipid-lowering medications are the most often utilized medications.
The hospitals segment hold the highest share in 2024 and is anticipated to grow at a significant CAGR during the projected timeframe.
Based on the end-user, the pharmaceutical market is classified into hospitals, clinics, and others. Among these, the hospitals segment hold the highest share in 2024 and is anticipated to grow at a significant CAGR during the projected timeframe. The aging population, rising rates of chronic illnesses, and improvements in medical treatments have led to a growth in healthcare demands, which highlights the hospitals segment.
North America is estimated to hold the largest share of the pharmaceutical market over the forecast period.
Get more details on this report -
North America is estimated to hold the largest share of the pharmaceutical market over the forecast period. The market in North America is expanding due to its robust GDP, high healthcare spending per person, accessibility to expensive medications, and substantial healthcare expertise. Moreover, several strategic initiatives developed in the region by pharmaceutical businesses, both established and new, are a major contributors to regional growth.
Asia Pacific is predicted to have the highest CAGR growth in the pharmaceutical market over the forecast period. The primary factors driving the pharmaceutical market's growth are the region's aging population and the rate at which research is being done to introduce and develop novel medicines.
Major key players in the pharmaceutical market include AstraZeneca, AbbVie Inc., Sanofi, F. Hoffmann-La Roche Ltd., Johnson & Johnson Services, Inc., GSK plc, Bristol-Myers Squibb Company, Merck & Co., Inc., OPKO Health, Inc., Pfizer Inc., Novartis AG, Takeda Pharmaceutical Company Limited, and Others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Development
- In June 2023, AstraZeneca announced that IMJUDO (tremelimumab), their ground-breaking cancer treatment, is now going available in the United Arab Emirates. The launch represents a major breakthrough in cancer treatment, making the UAE one of the first nations in the Middle East to get access to the drug. Clinical studies have shown that IMJUDO is both effective and safe when used in conjunction with a variety of cancer types, such as hepatobiliary and metastatic non-small cell lung cancer.
Market Segment
- This study forecasts revenue at global, regional, and country levels from 2025 to 2035. Spherical Insights has segmented the pharmaceutical market based on the below-mentioned segments:
Global Pharmaceutical Market, By Molecule Type
- Conventional Drugs (Small Molecules)
- Biologics & Biosimilars (Large Molecules)
- Others
Global Pharmaceutical Market, By Product
- Branded
- Generics
Global Pharmaceutical Market, By Type
- Prescription
- OTC
Global Pharmaceutical Market, By Disease
- Cardiovascular diseases
- Cancer
- Diabetes
- Infectious diseases
- Neurological disorders
- Respiratory diseases
- Autoimmune diseases
- Mental health disorders
- Gastrointestinal disorders
- Women’s health Diseases
- Genetic and rare genetic diseases
- Dermatological conditions
- Obesity
- Renal diseases
- Liver conditions
- Hematological disorders
- Eye conditions
- Infertility conditions
- Endocrine disorders
- Allergies
- Others
Global Pharmaceutical Market, By Route of Administration
- Oral
- Parenteral
- Topical
- Inhalations
- Others
Global Pharmaceutical Market, By Formulation
- Tablets
- Sprays
- Injectable
- Capsules
- Others
Global Pharmaceutical Market, By Age Group
- Adults
- Children & Adolescents
- Geriatric
Global Pharmaceutical Market, By End-User
- Hospitals
- Clinics
- Others
Global Pharmaceutical Market, By Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?